SINGAPORE, 7 MARCH 2019 HSA UPDATES
HSA UPDATES NO 2/2019 HSA UPDATES ON OVERSEAS RECALL OF ANGIOTENSIN II RECEPTOR BLOCKERS The Health Sciences Authority (HSA) has been closely monitoring the presence of nitrosamine impurities in angiotensin II receptor blockers (ARBs)1 that are marketed in Singapore for the control of high blood pressure. ................
................
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related download
- acsm certified personal trainer
- testimony of rosemary gibson senior advisor the hastings
- singapore 7 march 2019 hsa updates
- patient information diovan dye o van valsartan
- impact of armed conflict on cardiovascular disease risk a
- fs antihemophilic factor recombinant 27118rk and
- core family medicine
- preventive care services cigna
- silverscript choice pdp 2019 formulary
- august 2019 drug removals for clients with advanced